SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q1 Trading Update

18 Apr 2019 07:00

RNS Number : 5559W
Rentokil Initial PLC
18 April 2019
 

 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

18 April 2019

 

(£m)

 

Q1 2019

Growth

 

 

AER

AER

CER

Ongoing Revenue1

 

603.6

10.6%

8.9%

Revenue

 

607.4

10.3%

8.6%

 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue1 increasing by 8.9%, of which 4.0% was Organic Revenue2 growth (Q1 2018: 3.2%, FY 2018: 3.7%) and 4.9% was from acquisitions.

Ongoing Revenue in Pest Control grew by 12.0%, 5.0% Organic (Q1 2018: 4.7%), with good performances being delivered across both Growth and Emerging markets, which rose by 12.1% and 11.5% respectively. Hygiene has made a very positive start to the year, with Ongoing Revenue growth of 7.2% and Organic Revenue growth of 4.3% (Q1 2018: 1.8%). Ongoing Revenue in our Protect & Enhance markets was in line with Q1 2018.

M&A

​We signed eight acquisitions in Q1, four in Pest Control (primarily in North America and Latin America) and four in Hygiene, with combined annualised revenues of c. £29m in the year prior to purchase. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong. Our guidance for M&A spend in 2019 remains in the range of £200m to £250m.  

Pension Scheme and Funding

In December 2018 the Company reached agreement for a bulk annuity insurance 'buy-in' for its UK Defined Benefit Pension scheme ("the Scheme") in contemplation of a full 'buy-out' which is expected to complete in early 2020. Good progress towards buy-out is being made and we now anticipate a pre-tax cash surplus of c. £40m will be returned to the Company on completion.

Ahead of the refinancing of our €500m bond maturing in September this year, we are intending to hold a non-deal, bond investor education roadshow in London, France, Germany, the Netherlands, Nordics and Asia. We will release further details in due course.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"We have had a good start to 2019 and I'm pleased with our performance in the first three months of this year. I am confident of another year of successful growth for the Company, in line with market expectations."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

 

 

 

 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

 

 

 

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

AER - actual exchange rates; CER - constant 2018 exchange rates

 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTZMGMDRNMGLZM
Date   Source Headline
1st Nov 20134:55 pmRNSHolding(s) in Company
1st Nov 20133:13 pmRNSHolding(s) in Company
29th Oct 20133:18 pmRNSHolding(s) in Company
10th Oct 201310:56 amRNSStabilisation Notice
7th Oct 20134:04 pmRNSDirector/PDMR Shareholding
3rd Oct 20133:53 pmRNSPublication of Prospectus
27th Sep 20133:40 pmRNSIssue of new Eur350m bond
27th Sep 20131:28 pmRNSStabilisation Notice
18th Sep 201312:33 pmRNSDirector/PDMR Shareholding
13th Sep 20131:57 pmRNSHolding(s) in Company
29th Aug 20134:53 pmRNSPublication of Prospectus
15th Aug 201311:00 amRNSDirector/PDMR Shareholding
14th Aug 20137:00 amRNSHalf Yearly Report
1st Aug 20137:00 amRNSDirectorate Change
2nd Jul 20135:27 pmRNSDirector/PDMR Shareholding
21st Jun 20132:04 pmRNSPublication of Prospectus
18th Jun 20133:59 pmRNSHolding(s) in Company
24th May 20138:39 amRNSDirector/PDMR Shareholding
16th May 201312:14 pmRNSResults of AGM 2013
3rd May 20135:37 pmRNSDirector/PDMR Shareholding
1st May 20131:00 pmRNSDirector/PDMR Shareholding
29th Apr 20137:00 amRNS1st Quarter Results
29th Apr 20137:00 amRNSRentokil Initial announces the sale of City Link
19th Apr 20134:31 pmRNSHolding(s) in Company
17th Apr 201311:54 amRNSAnnual Financial Report
15th Mar 20137:01 amRNSDirectorate Change
15th Mar 20137:00 amRNSFinal Results
7th Jan 20135:18 pmRNSHolding(s) in Company
7th Jan 20135:07 pmRNSHolding(s) in Company
10th Dec 20127:00 amRNSCompletion of Acquisitions
27th Nov 20129:37 amRNSPublication of Supplementary Prospectus
9th Nov 20127:00 amRNSINTERIM MANAGEMENT STATEMENT - Q3
30th Oct 20123:12 pmRNSHolding(s) in Company
30th Oct 20122:48 pmRNSHolding(s) in Company
26th Oct 20123:06 pmRNSHolding(s) in Company
24th Oct 20129:54 amRNSHolding(s) in Company
19th Oct 20125:29 pmRNSHolding(s) in Company
17th Oct 20122:41 pmRNSHolding(s) in Company
16th Oct 20121:48 pmRNSHolding(s) in Company
16th Oct 201210:08 amRNSRepurchase of EUR 500m 2014 Bonds
12th Oct 20124:06 pmRNSHolding(s) in Company
10th Oct 20125:13 pmRNSHolding(s) in Company
9th Oct 201210:27 amRNSRedemption of Floating Rate Reset Notes
25th Sep 20127:00 amRNSAcquisition
21st Sep 20122:00 pmRNSHolding(s) in Company
20th Sep 20125:38 pmRNSPublication of Prospectus
20th Sep 20122:12 pmRNSHolding(s) in Company
17th Sep 20123:15 pmRNSIssue of new EUR 500m bond
14th Sep 20125:32 pmRNSPublication of Prospectus
14th Sep 20122:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.